Orforglipron Tablets

Orforglipron is an orally bioavailable GLP-1 receptor agonist studied for its impact on appetite regulation, metabolic pathways, glucose control, and long-term energy balance.

Unlike traditional GLP-1 peptides that require injection, Orforglipron delivers systemic GLP-1 activation through a capsule-based format—offering researchers a groundbreaking opportunity to examine incretin biology, adherence modeling, and metabolic control in a simplified delivery system.